Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease
Inflammatory Bowel Diseases2008Vol. 15(6), pp. 816–822
Citations Over TimeTop 10% of 2008 papers
Jeffrey S. Hyams, Trudy Lerer, Anne M. Griffiths, Marian Pfefferkorn, Subra Kugathasan, Jonathan Evans, Anthony Otley, Ryan Carvalho, David Mack, Athos Bousvaros, Joel R. Rosh, Petar Mamula, Marsha Kay, Wallace Crandall, Maria Oliva‐Hemker, David J. Keljo, Neal S. LeLeiko, James Markowitz
Abstract
Infliximab maintenance therapy was a durable and effective treatment that was associated with prolonged corticosteroid withdrawal over a 3-year period in children with CD.
Related Papers
- → Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease(2008)181 cited
- → Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease†(2009)17 cited
- → Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study(2015)14 cited
- → Results of Seton Drainage and Infliximab Infusion for Complex Anal Crohn's Disease(2011)9 cited
- → Infliximab therapy in Crohn's disease: a pragmatic approach?(2006)8 cited